ANDA 76188, held by Upsher Smith Labs. Fosinopril Sodium.
As of Nov 16, 2026, ANDA 76188 (Fosinopril Sodium), held by Upsher Smith Labs, was first approved by FDA on Oct 8, 2004, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 8, 2004 | Original application | Approved | None posted |
| Fosinopril Sodium10MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium20MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Fosinopril Sodium40MG · tablet;oral | Fosinopril Sodium | Discontinued |
| Jan 13, 2016 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 8, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters